Emiliano Santarnecchi, Ph.D., Psy.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Transcranial Magnetic Stimulation | 52 | 2024 | 1473 | 6.150 |
Why?
|
| Nerve Net | 15 | 2022 | 2291 | 3.210 |
Why?
|
| Intelligence | 10 | 2021 | 924 | 3.140 |
Why?
|
| Motor Cortex | 19 | 2024 | 1007 | 2.990 |
Why?
|
| Brain | 60 | 2023 | 27121 | 2.850 |
Why?
|
| Alzheimer Disease | 27 | 2024 | 8601 | 2.390 |
Why?
|
| Placebo Effect | 4 | 2024 | 518 | 2.380 |
Why?
|
| Video Games | 4 | 2021 | 198 | 2.030 |
Why?
|
| Evoked Potentials, Motor | 15 | 2024 | 464 | 1.960 |
Why?
|
| Brain Mapping | 17 | 2022 | 6635 | 1.720 |
Why?
|
| Executive Function | 7 | 2021 | 1392 | 1.690 |
Why?
|
| Cognitive Reserve | 3 | 2023 | 92 | 1.530 |
Why?
|
| Electroencephalography | 26 | 2023 | 6237 | 1.430 |
Why?
|
| Neurodegenerative Diseases | 4 | 2024 | 1088 | 1.330 |
Why?
|
| Cognition | 16 | 2023 | 6992 | 1.200 |
Why?
|
| Space Flight | 2 | 2020 | 215 | 1.150 |
Why?
|
| Magnetic Resonance Imaging | 38 | 2024 | 36426 | 1.030 |
Why?
|
| Cerebral Cortex | 6 | 2020 | 5779 | 1.010 |
Why?
|
| Memory, Short-Term | 4 | 2022 | 982 | 0.990 |
Why?
|
| Thalamus | 5 | 2021 | 1047 | 0.930 |
Why?
|
| Frontotemporal Lobar Degeneration | 2 | 2023 | 102 | 0.930 |
Why?
|
| Individuality | 3 | 2021 | 301 | 0.900 |
Why?
|
| Frontotemporal Dementia | 2 | 2024 | 247 | 0.890 |
Why?
|
| Neuronal Plasticity | 6 | 2023 | 1436 | 0.880 |
Why?
|
| Rest | 6 | 2021 | 918 | 0.880 |
Why?
|
| Parvalbumins | 1 | 2024 | 261 | 0.830 |
Why?
|
| Theta Rhythm | 3 | 2023 | 220 | 0.760 |
Why?
|
| Alpha Rhythm | 2 | 2019 | 111 | 0.750 |
Why?
|
| Problem Solving | 3 | 2021 | 443 | 0.730 |
Why?
|
| Psychomotor Performance | 3 | 2018 | 1882 | 0.720 |
Why?
|
| tau Proteins | 5 | 2022 | 2095 | 0.700 |
Why?
|
| Neural Pathways | 8 | 2021 | 3060 | 0.690 |
Why?
|
| Models, Neurological | 3 | 2021 | 1769 | 0.670 |
Why?
|
| Interneurons | 1 | 2024 | 593 | 0.670 |
Why?
|
| Humans | 137 | 2024 | 761596 | 0.660 |
Why?
|
| Weightlessness | 1 | 2020 | 102 | 0.650 |
Why?
|
| Attention | 5 | 2022 | 2396 | 0.610 |
Why?
|
| Temporal Lobe | 3 | 2022 | 1695 | 0.600 |
Why?
|
| Game Theory | 1 | 2017 | 23 | 0.600 |
Why?
|
| Athletic Performance | 1 | 2018 | 111 | 0.580 |
Why?
|
| Semantics | 1 | 2021 | 613 | 0.560 |
Why?
|
| Pyramidal Tracts | 4 | 2021 | 252 | 0.550 |
Why?
|
| Young Adult | 35 | 2024 | 59260 | 0.550 |
Why?
|
| Conversion Disorder | 1 | 2019 | 202 | 0.530 |
Why?
|
| Aging | 7 | 2021 | 8710 | 0.510 |
Why?
|
| Adult | 58 | 2024 | 221210 | 0.500 |
Why?
|
| Amantadine | 1 | 2015 | 57 | 0.500 |
Why?
|
| Electric Stimulation Therapy | 1 | 2021 | 628 | 0.500 |
Why?
|
| Memory Disorders | 3 | 2022 | 1199 | 0.490 |
Why?
|
| Deep Brain Stimulation | 2 | 2021 | 832 | 0.490 |
Why?
|
| Sleep Apnea, Obstructive | 2 | 2021 | 1875 | 0.480 |
Why?
|
| Corpus Striatum | 1 | 2021 | 1235 | 0.470 |
Why?
|
| Choroid Plexus | 3 | 2023 | 240 | 0.460 |
Why?
|
| Feasibility Studies | 2 | 2024 | 5247 | 0.440 |
Why?
|
| Cerebellum | 1 | 2021 | 1501 | 0.440 |
Why?
|
| Positron-Emission Tomography | 8 | 2022 | 6484 | 0.430 |
Why?
|
| Models, Theoretical | 3 | 2020 | 3575 | 0.430 |
Why?
|
| Prefrontal Cortex | 7 | 2022 | 2220 | 0.420 |
Why?
|
| Male | 66 | 2024 | 360846 | 0.420 |
Why?
|
| Visual Pathways | 1 | 2017 | 551 | 0.420 |
Why?
|
| Psychology | 1 | 2014 | 356 | 0.410 |
Why?
|
| Electric Stimulation | 2 | 2018 | 1736 | 0.410 |
Why?
|
| Weight Lifting | 1 | 2012 | 130 | 0.380 |
Why?
|
| Organ Size | 6 | 2020 | 2254 | 0.370 |
Why?
|
| Sexuality | 1 | 2013 | 180 | 0.370 |
Why?
|
| Female | 59 | 2024 | 392705 | 0.370 |
Why?
|
| Temperament | 1 | 2013 | 297 | 0.350 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2021 | 1469 | 0.350 |
Why?
|
| Psychological Tests | 1 | 2012 | 640 | 0.340 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 2013 | 357 | 0.330 |
Why?
|
| Brain Neoplasms | 2 | 2021 | 9032 | 0.320 |
Why?
|
| Transsexualism | 1 | 2012 | 208 | 0.310 |
Why?
|
| Stress, Psychological | 3 | 2021 | 4481 | 0.310 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2018 | 1081 | 0.310 |
Why?
|
| alpha-Synuclein | 2 | 2020 | 750 | 0.300 |
Why?
|
| Body Dysmorphic Disorders | 1 | 2012 | 243 | 0.300 |
Why?
|
| Fatigue | 1 | 2015 | 1552 | 0.300 |
Why?
|
| Amyloid beta-Peptides | 5 | 2022 | 3839 | 0.300 |
Why?
|
| Pilot Projects | 8 | 2024 | 8633 | 0.290 |
Why?
|
| Adaptation, Psychological | 1 | 2018 | 2629 | 0.280 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2022 | 3708 | 0.280 |
Why?
|
| Motor Skills | 3 | 2021 | 521 | 0.280 |
Why?
|
| Models, Biological | 2 | 2020 | 9469 | 0.280 |
Why?
|
| Parietal Lobe | 6 | 2024 | 852 | 0.270 |
Why?
|
| Intelligence Tests | 2 | 2020 | 503 | 0.270 |
Why?
|
| Artificial Intelligence | 1 | 2021 | 2578 | 0.270 |
Why?
|
| Amyloid | 2 | 2018 | 841 | 0.270 |
Why?
|
| Glioma | 1 | 2021 | 3455 | 0.270 |
Why?
|
| Epilepsy, Temporal Lobe | 2 | 2020 | 389 | 0.260 |
Why?
|
| Substance-Related Disorders | 1 | 2022 | 4420 | 0.260 |
Why?
|
| Multiple Sclerosis | 3 | 2015 | 3222 | 0.260 |
Why?
|
| Reproducibility of Results | 8 | 2023 | 20100 | 0.250 |
Why?
|
| Eye Movement Desensitization Reprocessing | 2 | 2017 | 5 | 0.250 |
Why?
|
| Meditation | 2 | 2021 | 251 | 0.240 |
Why?
|
| Athletes | 1 | 2012 | 1137 | 0.230 |
Why?
|
| Middle Aged | 24 | 2024 | 220921 | 0.230 |
Why?
|
| Glioblastoma | 1 | 2019 | 3483 | 0.230 |
Why?
|
| Anxiety | 2 | 2024 | 4573 | 0.230 |
Why?
|
| Sex Characteristics | 4 | 2018 | 2639 | 0.220 |
Why?
|
| Neuropsychological Tests | 5 | 2022 | 7054 | 0.220 |
Why?
|
| Fingers | 2 | 2017 | 507 | 0.220 |
Why?
|
| Knee | 1 | 2024 | 279 | 0.210 |
Why?
|
| Stereotaxic Techniques | 2 | 2022 | 555 | 0.210 |
Why?
|
| Cerebrovascular Circulation | 3 | 2019 | 2727 | 0.200 |
Why?
|
| Aged | 18 | 2024 | 169310 | 0.200 |
Why?
|
| Italy | 3 | 2013 | 842 | 0.200 |
Why?
|
| Resistance Training | 1 | 2024 | 193 | 0.200 |
Why?
|
| Lewy Body Disease | 1 | 2024 | 252 | 0.200 |
Why?
|
| Depression | 1 | 2021 | 8126 | 0.200 |
Why?
|
| Macaca | 1 | 2023 | 410 | 0.190 |
Why?
|
| Anxiety Disorders | 1 | 2013 | 2720 | 0.190 |
Why?
|
| Recruitment, Neurophysiological | 1 | 2021 | 33 | 0.190 |
Why?
|
| Vestibule, Labyrinth | 1 | 2023 | 234 | 0.190 |
Why?
|
| Brain Waves | 2 | 2017 | 409 | 0.180 |
Why?
|
| Defense Mechanisms | 2 | 2020 | 180 | 0.180 |
Why?
|
| Hippocampus | 4 | 2021 | 3766 | 0.180 |
Why?
|
| Aphasia, Primary Progressive | 1 | 2021 | 84 | 0.180 |
Why?
|
| Entorhinal Cortex | 1 | 2022 | 287 | 0.170 |
Why?
|
| Long-Term Potentiation | 1 | 2021 | 293 | 0.170 |
Why?
|
| Auditory Cortex | 1 | 2024 | 363 | 0.170 |
Why?
|
| Astronauts | 1 | 2020 | 92 | 0.170 |
Why?
|
| Forecasting | 2 | 2020 | 2928 | 0.170 |
Why?
|
| Twins | 1 | 2021 | 339 | 0.170 |
Why?
|
| Thumb | 1 | 2021 | 232 | 0.170 |
Why?
|
| Adolescent | 10 | 2021 | 88326 | 0.160 |
Why?
|
| Mental Recall | 3 | 2017 | 1221 | 0.160 |
Why?
|
| Off-Label Use | 1 | 2021 | 185 | 0.160 |
Why?
|
| Likelihood Functions | 1 | 2022 | 992 | 0.160 |
Why?
|
| Neuromuscular Junction | 1 | 2021 | 405 | 0.160 |
Why?
|
| Speech Perception | 1 | 2024 | 509 | 0.160 |
Why?
|
| Emotions | 2 | 2022 | 2739 | 0.160 |
Why?
|
| Task Performance and Analysis | 1 | 2022 | 763 | 0.150 |
Why?
|
| Object Attachment | 2 | 2020 | 326 | 0.150 |
Why?
|
| Delirium | 2 | 2022 | 1668 | 0.150 |
Why?
|
| Muscle, Skeletal | 5 | 2024 | 4948 | 0.150 |
Why?
|
| Adaptation, Physiological | 1 | 2024 | 1301 | 0.150 |
Why?
|
| Imagination | 1 | 2019 | 226 | 0.150 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2024 | 781 | 0.150 |
Why?
|
| Paranoid Disorders | 1 | 2017 | 61 | 0.140 |
Why?
|
| Neocortex | 1 | 2021 | 417 | 0.140 |
Why?
|
| Electrodes | 1 | 2019 | 614 | 0.140 |
Why?
|
| Neuronavigation | 1 | 2018 | 166 | 0.140 |
Why?
|
| Perfusion | 1 | 2021 | 1373 | 0.140 |
Why?
|
| Memory | 2 | 2017 | 2193 | 0.140 |
Why?
|
| Age of Onset | 3 | 2019 | 3306 | 0.140 |
Why?
|
| Learning | 2 | 2023 | 1740 | 0.140 |
Why?
|
| Cochlear Implantation | 1 | 2021 | 316 | 0.130 |
Why?
|
| Diagnostic Self Evaluation | 2 | 2018 | 224 | 0.130 |
Why?
|
| Parahippocampal Gyrus | 1 | 2017 | 115 | 0.130 |
Why?
|
| Piracetam | 1 | 2017 | 88 | 0.130 |
Why?
|
| Cochlear Implants | 1 | 2021 | 339 | 0.130 |
Why?
|
| Electroconvulsive Therapy | 1 | 2021 | 500 | 0.130 |
Why?
|
| Benchmarking | 1 | 2022 | 1045 | 0.130 |
Why?
|
| Nootropic Agents | 1 | 2017 | 157 | 0.130 |
Why?
|
| Bisexuality | 1 | 2017 | 294 | 0.130 |
Why?
|
| Gyrus Cinguli | 1 | 2021 | 1115 | 0.130 |
Why?
|
| Equipment Design | 2 | 2021 | 3511 | 0.120 |
Why?
|
| Physical Endurance | 1 | 2017 | 366 | 0.120 |
Why?
|
| Environment | 1 | 2021 | 1123 | 0.120 |
Why?
|
| Visual Perception | 2 | 2023 | 1389 | 0.120 |
Why?
|
| Robotics | 1 | 2021 | 819 | 0.120 |
Why?
|
| Transcutaneous Electric Nerve Stimulation | 1 | 2017 | 170 | 0.120 |
Why?
|
| Neuroanatomy | 1 | 2014 | 70 | 0.120 |
Why?
|
| Auditory Perception | 1 | 2019 | 583 | 0.120 |
Why?
|
| Sleep | 2 | 2020 | 4768 | 0.110 |
Why?
|
| Fear | 2 | 2020 | 1477 | 0.110 |
Why?
|
| Nontherapeutic Human Experimentation | 1 | 2013 | 22 | 0.110 |
Why?
|
| Stress Disorders, Post-Traumatic | 3 | 2018 | 4575 | 0.110 |
Why?
|
| Angiography, Digital Subtraction | 1 | 2015 | 335 | 0.110 |
Why?
|
| Longitudinal Studies | 2 | 2021 | 14608 | 0.110 |
Why?
|
| Psychotherapy | 1 | 2022 | 1647 | 0.110 |
Why?
|
| Resilience, Psychological | 1 | 2021 | 788 | 0.110 |
Why?
|
| Microglia | 1 | 2022 | 1362 | 0.100 |
Why?
|
| Quality of Life | 3 | 2020 | 13367 | 0.100 |
Why?
|
| Ataxia Telangiectasia | 1 | 2013 | 107 | 0.100 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 2 | 2021 | 2791 | 0.100 |
Why?
|
| Neurotransmitter Agents | 1 | 2016 | 665 | 0.100 |
Why?
|
| Evoked Potentials | 3 | 2023 | 1047 | 0.100 |
Why?
|
| Language | 1 | 2021 | 1543 | 0.100 |
Why?
|
| Body Constitution | 1 | 2012 | 273 | 0.100 |
Why?
|
| Mental Disorders | 2 | 2022 | 6845 | 0.100 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 2020 | 1491 | 0.090 |
Why?
|
| Functional Laterality | 2 | 2020 | 2257 | 0.090 |
Why?
|
| Efferent Pathways | 1 | 2011 | 165 | 0.090 |
Why?
|
| Animals | 7 | 2024 | 168475 | 0.090 |
Why?
|
| Case-Control Studies | 5 | 2020 | 22176 | 0.090 |
Why?
|
| Thinking | 1 | 2013 | 320 | 0.090 |
Why?
|
| Time Factors | 6 | 2019 | 39969 | 0.090 |
Why?
|
| Double-Blind Method | 5 | 2024 | 12341 | 0.090 |
Why?
|
| Movement | 1 | 2017 | 1478 | 0.090 |
Why?
|
| Dementia | 1 | 2024 | 2689 | 0.080 |
Why?
|
| Interpersonal Relations | 1 | 2017 | 1436 | 0.080 |
Why?
|
| Cognition Disorders | 1 | 2024 | 3980 | 0.080 |
Why?
|
| Sclerosis | 2 | 2020 | 210 | 0.080 |
Why?
|
| Panic Disorder | 1 | 2013 | 613 | 0.080 |
Why?
|
| Teaching | 1 | 2017 | 1170 | 0.080 |
Why?
|
| Factor Analysis, Statistical | 1 | 2012 | 999 | 0.080 |
Why?
|
| Treatment Outcome | 6 | 2024 | 64685 | 0.080 |
Why?
|
| Siblings | 1 | 2013 | 825 | 0.080 |
Why?
|
| Personality Inventory | 1 | 2012 | 1019 | 0.080 |
Why?
|
| Antineoplastic Agents | 2 | 2024 | 13642 | 0.080 |
Why?
|
| Principal Component Analysis | 1 | 2012 | 945 | 0.080 |
Why?
|
| Somatosensory Cortex | 1 | 2011 | 512 | 0.070 |
Why?
|
| Aged, 80 and over | 4 | 2022 | 58984 | 0.070 |
Why?
|
| Combined Modality Therapy | 1 | 2019 | 8527 | 0.070 |
Why?
|
| Pain | 3 | 2019 | 5073 | 0.070 |
Why?
|
| Mice | 3 | 2024 | 81539 | 0.070 |
Why?
|
| Muscles | 1 | 2012 | 1576 | 0.070 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2018 | 2400 | 0.070 |
Why?
|
| Arousal | 1 | 2013 | 1166 | 0.070 |
Why?
|
| Databases, Genetic | 1 | 2014 | 1742 | 0.070 |
Why?
|
| Sensitivity and Specificity | 1 | 2022 | 14665 | 0.070 |
Why?
|
| Diagnosis, Differential | 1 | 2022 | 12973 | 0.070 |
Why?
|
| Psychometrics | 2 | 2017 | 3065 | 0.070 |
Why?
|
| Child, Preschool | 3 | 2021 | 42232 | 0.070 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2014 | 1496 | 0.070 |
Why?
|
| Gender Identity | 1 | 2012 | 766 | 0.070 |
Why?
|
| Self Report | 1 | 2018 | 3725 | 0.070 |
Why?
|
| Cross-Sectional Studies | 5 | 2019 | 26129 | 0.070 |
Why?
|
| Hydrocortisone | 1 | 2014 | 1819 | 0.070 |
Why?
|
| Computer Simulation | 1 | 2019 | 6241 | 0.060 |
Why?
|
| Polysomnography | 1 | 2012 | 1848 | 0.060 |
Why?
|
| Genetic Variation | 1 | 2021 | 6567 | 0.060 |
Why?
|
| Parkinson Disease | 1 | 2020 | 2877 | 0.060 |
Why?
|
| Disabled Persons | 1 | 2015 | 1226 | 0.060 |
Why?
|
| Clinical Competence | 1 | 2020 | 4793 | 0.060 |
Why?
|
| Disease Progression | 2 | 2019 | 13510 | 0.060 |
Why?
|
| Glucocorticoids | 1 | 2014 | 2161 | 0.060 |
Why?
|
| Isometric Contraction | 1 | 2024 | 150 | 0.060 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2013 | 2009 | 0.060 |
Why?
|
| Biomedical Research | 1 | 2019 | 3429 | 0.060 |
Why?
|
| Apolipoprotein E4 | 1 | 2018 | 709 | 0.060 |
Why?
|
| Speech Intelligibility | 1 | 2024 | 79 | 0.060 |
Why?
|
| Oxygen | 1 | 2015 | 4227 | 0.050 |
Why?
|
| Neurons | 1 | 2023 | 9463 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 7391 | 0.050 |
Why?
|
| Mental Health | 1 | 2017 | 3250 | 0.050 |
Why?
|
| Electromyography | 2 | 2019 | 1394 | 0.050 |
Why?
|
| Exercise | 1 | 2019 | 5890 | 0.050 |
Why?
|
| Amyloidogenic Proteins | 1 | 2023 | 151 | 0.050 |
Why?
|
| Linear Models | 1 | 2013 | 5872 | 0.050 |
Why?
|
| Schizophrenia | 1 | 2021 | 6937 | 0.050 |
Why?
|
| Apolipoproteins E | 1 | 2018 | 1443 | 0.050 |
Why?
|
| Articulation Disorders | 1 | 2021 | 11 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2019 | 10212 | 0.050 |
Why?
|
| Health Status | 1 | 2014 | 4077 | 0.050 |
Why?
|
| Electrophysiological Phenomena | 1 | 2023 | 307 | 0.050 |
Why?
|
| Nausea | 1 | 2023 | 679 | 0.040 |
Why?
|
| Stroke | 1 | 2023 | 9758 | 0.040 |
Why?
|
| Sensation | 1 | 2022 | 337 | 0.040 |
Why?
|
| Artificial Limbs | 1 | 2021 | 121 | 0.040 |
Why?
|
| Physical Therapy Modalities | 1 | 2023 | 532 | 0.040 |
Why?
|
| Hand Strength | 1 | 2023 | 456 | 0.040 |
Why?
|
| Activities of Daily Living | 2 | 2022 | 2421 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2015 | 9001 | 0.040 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 12059 | 0.040 |
Why?
|
| Child | 2 | 2020 | 80158 | 0.040 |
Why?
|
| Upper Extremity | 1 | 2023 | 658 | 0.040 |
Why?
|
| Neurophysiology | 1 | 2018 | 144 | 0.030 |
Why?
|
| Heart Rate | 2 | 2019 | 4195 | 0.030 |
Why?
|
| Negotiating | 1 | 2018 | 150 | 0.030 |
Why?
|
| Glucose | 1 | 2018 | 4347 | 0.030 |
Why?
|
| Motor Neurons | 1 | 2021 | 870 | 0.030 |
Why?
|
| Aggression | 1 | 2021 | 750 | 0.030 |
Why?
|
| Fourier Analysis | 1 | 2017 | 441 | 0.030 |
Why?
|
| Theory of Mind | 1 | 2017 | 91 | 0.030 |
Why?
|
| Frontal Lobe | 1 | 2022 | 1420 | 0.030 |
Why?
|
| Shoulder | 1 | 2017 | 300 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2019 | 12149 | 0.030 |
Why?
|
| Cohort Studies | 2 | 2018 | 41495 | 0.030 |
Why?
|
| Research Design | 2 | 2023 | 6180 | 0.030 |
Why?
|
| Neoplasms | 1 | 2024 | 22173 | 0.030 |
Why?
|
| Physical Exertion | 1 | 2017 | 667 | 0.030 |
Why?
|
| Artifacts | 1 | 2023 | 1911 | 0.030 |
Why?
|
| Atrophy | 1 | 2019 | 1633 | 0.030 |
Why?
|
| Sex Factors | 1 | 2018 | 10554 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2018 | 1574 | 0.030 |
Why?
|
| Systems Biology | 1 | 2018 | 481 | 0.030 |
Why?
|
| Risk Factors | 2 | 2018 | 74213 | 0.030 |
Why?
|
| Hearing Loss | 1 | 2021 | 783 | 0.030 |
Why?
|
| Psycholinguistics | 1 | 2013 | 79 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2020 | 2330 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2023 | 2979 | 0.030 |
Why?
|
| Universities | 1 | 2017 | 993 | 0.030 |
Why?
|
| Lactic Acid | 1 | 2017 | 1139 | 0.030 |
Why?
|
| Ulnar Nerve | 1 | 2011 | 102 | 0.020 |
Why?
|
| Educational Status | 1 | 2018 | 2522 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 2017 | 2079 | 0.020 |
Why?
|
| Neurology | 1 | 2018 | 780 | 0.020 |
Why?
|
| Skin | 1 | 2022 | 4484 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2018 | 6345 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2017 | 6228 | 0.020 |
Why?
|
| Students | 1 | 2017 | 1741 | 0.020 |
Why?
|
| Photic Stimulation | 1 | 2013 | 1987 | 0.020 |
Why?
|
| Disability Evaluation | 1 | 2014 | 1836 | 0.020 |
Why?
|
| ROC Curve | 1 | 2014 | 3578 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2018 | 39106 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2017 | 10766 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2019 | 9319 | 0.010 |
Why?
|
| Health Surveys | 1 | 2014 | 4061 | 0.010 |
Why?
|
| Recurrence | 1 | 2015 | 8466 | 0.010 |
Why?
|
| Age Factors | 1 | 2018 | 18399 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 22174 | 0.010 |
Why?
|
| Prevalence | 1 | 2017 | 15733 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 15266 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 15843 | 0.010 |
Why?
|